Summit Materials Inc

Summit Materials Inc (SUM) News & Events

$52.490

0.000 (0.00%)At close

SUM News

SUM Events

2/10 11:39

Summit Materials completes merger with Quikrete

Summit Materials announced the closing of its previously announced definitive agreement to be acquired by Quikrete Holdings for $52.50 per share in cash, for a total enterprise value of approximately $11.5B, including debt. Summit's common stock has ceased trading on the NYSE and will no longer be listed on any public market. Additionally, the company has become a privately held subsidiary of Quikrete.

1/9 07:31

Summit Materials announces expiration of Competition Act waiting period for deal

Summit Materials announced the expiration of the waiting period under the Competition Act, as amended, in connection with Summit's previously announced definitive agreement to be acquired by Quikrete Holdings for $52.50 per share in cash. The merger is expected to close within the first quarter of 2025, subject to the satisfaction of remaining customary closing conditions, as well as receipt of regulatory approvals and Summit stockholder approval. Upon completion of the merger, Summit will become a privately held subsidiary of Quikrete and its common stock will no longer be traded on the NYSE.

1/7 11:11

Summit Materials announces expiration of HSR Act waiting period for acquisition

Summit Materials announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in connection with Summit's previously announced definitive agreement to be acquired by Quikrete Holdings for $52.50 per share in cash. The Merger is expected to close within the first quarter of 2025, subject to the satisfaction of remaining customary closing conditions, as well as receipt of regulatory approvals and Summit stockholder approval. Upon completion of the Merger, Summit will become a privately held subsidiary of Quikrete and its common stock will no longer be traded on the NYSE.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started